The side effects of slimming injections attract attention! Diabetes Health Education Association plans to launch "Asia's first guidelines"

In recent years, the incretin drug, commonly known as the "slimming shot", has been released. In addition to diabetic patients, many people use it to lose weight. However, the side effects have gradually attracted attention from all walks of life. The Diabetes Health Education Society plans to invite other domestic societies to participate, and will work with Japan, South Korea and other Asian countries to develop Asia's first special guidelines covering the prevention, response and reminders of side effects related to slimming injections, and hopes to publish them in international academic journals in January next year.

Ou Hongyi, chairman of the Diabetes Health Education Association, pointed out that there are many situations that require special attention after using the "Slimming Injection". For example, before surgery or anesthesia, if there is food in the stomach, it may cause choking and cause danger. GLP-1 drugs will slow down the gastric emptying speed after use, allowing food to stay in the stomach for a long time. Therefore, users need to stop taking the drug 2 weeks in advance before surgery or anesthesia.

Ou Hongyi said that if people are taking related drugs due to more severe diabetes, the hospital's diabetes care team will intervene and evaluate before surgery, and adjust the medication according to the patient's condition to ensure that the patient's blood sugar can be controlled within a safe range after stopping the medication. If the patient is already hospitalized, insulin will usually be used directly during hospitalization.

In addition, Ou Hongyi mentioned that the society has noticed the importance of medication safety and avoiding side effects for slimming needle users. It is currently planning to invite representatives from different domestic societies to participate in discussions and jointly develop formal guidelines with Japan, South Korea and other Asian countries to address the side effects of slimming needles for various purposes such as weight loss and diabetes control, including whether medication needs to be discontinued in various situations such as surgery and hospitalization, and what response measures should be taken.

Ou Hongyi said that the guidelines also plan to include precautions when switching between different types of slimming injections, how to deal with excessive doses by mistake, and other all-encompassing scenarios. The society is also continuing to take stock of the content that should be included in the guidelines. It is expected to formulate a first draft by the end of November, and hopes to officially publish it through international academic journals in January next year. It is expected to become Asia's first precautions for the side effects of slimming injections.

Regarding the public's increasing attention to the side effects of slimming injections in recent years, Ou Hongyi emphasized that the benefits of incretin and related drugs do exist, and the side effects also need to be paid attention to and avoided through appropriate practices. The Society drafted such guidelines not to cause panic among the public, but to allow the drugs to play their maximum role under safe conditions.